Lung transplantation for primary and secondary pulmonary hypertension John V Conte, MD, Marvin J Borja, BS, Chandrahas B Patel, BS, Steven C Yang, MD, Rajiv M Jhaveri, MD, Jonathan B Orens, MD The Annals of Thoracic Surgery Volume 72, Issue 5, Pages 1673-1680 (November 2001) DOI: 10.1016/S0003-4975(01)03081-8
Fig 1 Kaplan-Meier survival curves for primary pulmonary hypertension group based on procedure performed. (ALL = acute lymphocytic leukemia; BLT = bilateral lung transplantations; SLT = single lung transplantations.) The Annals of Thoracic Surgery 2001 72, 1673-1680DOI: (10.1016/S0003-4975(01)03081-8)
Fig 2 Kaplan-Meier survival curve for secondary pulmonary hypertension group based on procedure performed. (ALL = acute lymphocytic leukemia; BLT = bilateral lung transplantations; n.s. = not significant; SLT = single lung transplantations.) The Annals of Thoracic Surgery 2001 72, 1673-1680DOI: (10.1016/S0003-4975(01)03081-8)
Fig 3 Kaplan-Meier survival curves for secondary pulmonary hypertension group based on mean pulmonary arterial pressure and transplant type. (BLT = bilateral lung transplantations; n.s. = not significant; pts = patients; SLT = single lung transplantations.) The Annals of Thoracic Surgery 2001 72, 1673-1680DOI: (10.1016/S0003-4975(01)03081-8)
Fig 4 Kaplan-Meier survival curve for all patients with mean pulmonary arterial pressure (PAM) more than 40 mm Hg based on transplant type. (BLT = bilateral lung transplantations; SLT = single lung transplantations.) The Annals of Thoracic Surgery 2001 72, 1673-1680DOI: (10.1016/S0003-4975(01)03081-8)